Related Experiment Videos
Parameters for neodymium-YAG laser trabeculotomy: an in-vitro study
G N Dutton1, S A Cameron, D Allan
1Tennent Institute of Ophthalmology, University of Glasgow.
The British Journal of Ophthalmology
|October 1, 1987
Summary
This study determined optimal neodymium-YAG laser settings for creating lesions in human trabecular meshwork in vitro. Precise energy levels are crucial for safe and effective laser trabeculotomy in glaucoma patients.
Area of Science:
- Ophthalmology
- Biophysics
- Medical Laser Technology
Background:
- Glaucoma treatment often involves procedures to reduce intraocular pressure.
- Laser trabeculotomy aims to improve aqueous humor outflow through the trabecular meshwork.
- Precise laser parameters are essential for surgical success and safety.
Purpose of the Study:
- To establish the energy levels of a Q-switched neodymium-YAG laser required to create lesions in human trabecular meshwork in vitro.
- To evaluate the efficacy of different laser convergence angles for lesion production.
- To provide data for optimizing short-pulsed laser internal trabeculotomy procedures.
Main Methods:
- Human corneoscleral tissue explants were used in an in vitro model.
- A Q-switched neodymium-YAG laser with a Trokel gonioscopic lens was employed.
- Lesions were created in the trabecular meshwork at varying energy levels (0.5-7.0 mJ) and convergence angles (10° and 18°).
Main Results:
- Discrete lesions in the trabecular meshwork, without scleral perforation, were achieved at 3.0-5.0 mJ (10° convergence) and 4.0-6.0 mJ (18° convergence).
- The neodymium-YAG laser successfully produced targeted lesions in the trabecular meshwork.
- Specific energy ranges were identified for safe lesion creation.
Conclusions:
- The study identified specific Q-switched neodymium-YAG laser energy levels for effective trabecular meshwork lesion creation in vitro.
- Determining these parameters is critical before clinical application of laser internal trabeculotomy.
- This research supports the development of safer and more precise glaucoma treatments.